https://www.auntminnie.com/clinical-news/molecular-imaging/article/15837390/molecular-imaging-insiderAuntMinnieen2026-10-13T20:21:02.000ZAuntMinnie.com Molecular Imaging Insiderhttps://www.auntminnie.com/clinical-news/molecular-imaging/nuclear-medicine/article/15837353/lu177-pnt2002-before-sbrt-extends-disease-control-in-prostate-cancerAuntMinnieen2026-10-13T18:41:18.000ZLu-177 PNT2002 before SBRT extends disease control in prostate cancerhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/prostate-imaging.mAL64wGUs6.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/imaging-informatics/artificial-intelligence/article/15837225/hpi-evidence-contradicts-broad-claims-about-ai-radiology-workforceAuntMinnieen2026-10-13T12:00:00.000ZHPI: Evidence contradicts broad claims about AI, radiology workforcehttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/ai-abstract-researcher.pRp5uOIab0.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/resources/conference/rsna/2026/article/15837274/coming-soonAuntMinnieen2026-10-12T23:13:30.000ZComing soon!https://www.auntminnie.com/editors-note/article/15837161/week-in-review-falsenegative-dbt-exams-interview-with-dennis-wulfeck-md-mri-safety-podcastAuntMinnieen2026-10-09T20:40:59.000ZWeek in Review: False-negative DBT exams | Interview with Dennis Wulfeck, MD | MRI safety podcasthttps://www.auntminnie.com/clinical-news/ct/article/15837148/new-dataset-maps-ldct-lung-cancer-screening-eligibilityAuntMinnieen2026-10-09T19:33:51.000ZNew dataset maps people eligible for LDCT lung cancer screeninghttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/ldct-screening-map.KJ2FZubsbE.jpg?auto=format%252Ccompress&q=70Largest and priority populations by county of those who are LCS eligible. LCS indicates lung cancer screening.https://www.auntminnie.com/clinical-news/mri/article/15837127/mri-patient-safety-positioning-risk-and-controlled-access-in-the-mr-environmentAuntMinnieen2026-10-09T18:26:11.000ZMRI patient safety, positioning risk, and controlled access in the MR environmenthttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/brandon-johnson.wZ1GWqe93Y.jpg?auto=format%252Ccompress&q=70Brandon Johnson.https://www.auntminnie.com/practice-management/careers/imaging-leaders/article/15836874/wulfeck-talks-uspstf-appointment-goalsAuntMinnieen2026-10-09T11:00:00.000Z5 questions with new USPSTF appointee Dennis Wulfeck, MD https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/dennis-wulfeck-headshot-0.zzr5In8eFO.jpg?auto=format%252Ccompress&q=70Dennis Wulfeck, MDhttps://www.auntminnie.com/practice-management/article/15837081/radiology-followup-rates-dismal-for-incarcerated-patientsAuntMinnieen2026-10-08T20:45:36.000ZRadiology follow-up rates dismal for incarcerated patientshttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/shutterstock-2439920485.WFJNmQPYPt.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/ultrasound/article/15837043/abus-recommended-over-hhus-in-breast-cancer-screeningAuntMinnieen2026-10-08T17:37:22.000ZABUS recommended over HHUS in breast cancer screeninghttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/breast-cancer.V5xj1KeNbG.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/imaging-informatics/artificial-intelligence/article/15836861/ai-leads-to-lower-turnaround-times-for-highvolume-imagingAuntMinnieen2026-10-08T12:22:00.000ZAI leads to lower turnaround times for high-volume imaginghttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/artificial-intelligence-ai-medical-healthcare-tools-400.drf6j1JBuf.jpg?auto=format%252Ccompress&q=70https://www.auntminnie.com/clinical-news/molecular-imaging/article/15836812/snmmi-psmapetctguided-biopsy-improves-prostate-cancer-detectionAuntMinnieen2026-10-07T17:21:58.000ZSNMMI: PSMA-PET/CT-guided biopsy improves prostate cancer detectionhttps://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/pet-ct-biopsy.2VunWQqmOL.jpg?auto=format%252Ccompress&q=70Upstage with PET-guided biopsy. A 70-y-old patient with suspicious prostate cancer (PI-RADS 2; initial PSA, 15.9; PSA density, 0.4). Exam showed intense focal gallium-68 PSMA-11 uptake (SUVmax, 9.5; PRIMARY score 4) in left peripheral zone at midlevel shown maximum-intensity projection (A), transaxial view of CT image (B), PET image (C), and transaxial fused PET/CT image (D). Transperineal PSMA-PET targeted prostate biopsy revealed clinically significant prostate cancer (csPCa), ISUP 5, whereas standard biopsy revealed csPCa, ISUP 2.